Correlation Between ESSA Pharma and Pfizer
Can any of the company-specific risk be diversified away by investing in both ESSA Pharma and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ESSA Pharma and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ESSA Pharma and Pfizer Inc, you can compare the effects of market volatilities on ESSA Pharma and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ESSA Pharma with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of ESSA Pharma and Pfizer.
Diversification Opportunities for ESSA Pharma and Pfizer
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between ESSA and Pfizer is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding ESSA Pharma and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and ESSA Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ESSA Pharma are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of ESSA Pharma i.e., ESSA Pharma and Pfizer go up and down completely randomly.
Pair Corralation between ESSA Pharma and Pfizer
Given the investment horizon of 90 days ESSA Pharma is expected to generate 4.09 times more return on investment than Pfizer. However, ESSA Pharma is 4.09 times more volatile than Pfizer Inc. It trades about 0.02 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.05 per unit of risk. If you would invest 273.00 in ESSA Pharma on October 13, 2024 and sell it today you would lose (99.00) from holding ESSA Pharma or give up 36.26% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 99.8% |
Values | Daily Returns |
ESSA Pharma vs. Pfizer Inc
Performance |
Timeline |
ESSA Pharma |
Pfizer Inc |
ESSA Pharma and Pfizer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ESSA Pharma and Pfizer
The main advantage of trading using opposite ESSA Pharma and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ESSA Pharma position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.ESSA Pharma vs. Summit Therapeutics PLC | ESSA Pharma vs. Avenue Therapeutics | ESSA Pharma vs. Spero Therapeutics |
Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
CEOs Directory Screen CEOs from public companies around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |